Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Uterine Cervical Neoplasms 1Prostatic Neoplasms 1Neoplasms 1Multiple Endocrine Neoplasia Type 1 1Fatigue 1Castration-Resistant Prostate Carcinoma 1Castration Resistant Metastatic Prostate Cancer 1Carcinoma, Squamous Cell 1Cachexia 1

Interventions

Megestrol Acetate 6Standard of Care 3Exercise 3Physical Therapy Modalities 2Nutrition Assessment 2Infliximab 2Blood Specimen Collection 2testosterone enanthate 1remune 1ostarine 1olanzapine-fluoxetine combination 1irinotecan sucrosofate 1clazakizumab 1bermekimab 1anamorelin 1Sodium Chloride 1Radiotherapy 1Preoperative Exercise 1Powders 1Pentoxifylline 1Olanzapine 1Nandrolone Decanoate 1Mirtazapine 1Melatonin 1Megestrol 1Immunologic Techniques 1Ibuprofen 1High-Energy Shock Waves 1Ghrelin 1Gemcitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Cachexia × testosterone enanthate × Clear all
NCT00878995 2018-03-12

Testosterone for Treating Cachexia in Patients With Squamous Cell Carcinoma

The University of Texas Medical Branch, Galveston

Phase 1 Completed
28 enrolled 55 charts
Gynecologic

Cachexia, Carcinoma, Squamous Cell, Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡